BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
Summary by The Record
2 Articles
2 Articles
All
Left
2
Center
Right


BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic neuroplastogen in the…
·Waterloo, Canada
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left2Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage